Ratings by WBB Securities (Stephen Brozak)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/22/2025 | Cidara Therapeutics | CDTX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 9/22/2021 | Cidara Therapeutics | CDTX | Upgrade | Strong Buy (Buy) |
2.09 (221.38) |
10492.34% | Details | |
| 8/11/2021 | CohBar | CWBR | Upgrade | Buy (Hold) |
1.29 (0.41) |
-68.22% | Details | |
| 6/9/2020 | Arcturus Therapeutics | ARCT | Downgrade | Hold (Buy) |
29.82 (6.82) |
-77.13% | Details | |
| 12/4/2019 | Cidara Therapeutics | CDTX | Upgrade | Buy (Hold) |
2.37 (221.38) |
9240.93% | Details | |
| 5/14/2019 | Caladrius Biosciences | CLBS | New Coverage | Speculative Buy (N/A) |
2.84 (0.43) |
-84.86% | Details |
